(Q34557766)

English

A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Ying Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ke-Chun Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Bing-Xiang Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Xin Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Xin Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Su Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Shu-Fang Nie

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Wei-San Pan

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Xuan Zhang

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Qiang Zhang

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

20 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Journal of Biomedicine and Biotechnology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2011

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

854872

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Microemulsions: a novel approach to enhanced drug delivery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Novel formulations of taxanes: a review. Old wine in a new bottle?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Improved drug delivery using microemulsions: rationale, recent progress, and new horizons.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Microemulsion-based media as novel drug delivery systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

The taxanes: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Clinical toxicities encountered with paclitaxel (Taxol).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Hypersensitivity reactions to teniposide (VM-26): an analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Taxol: a novel investigational antimicrotubule agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Hypersensitivity reactions from taxol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035038

7 July 2018

Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F854872

21 January 2018

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F854872

21 January 2018

Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F854872

21 January 2018

An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F854872

21 January 2018

Anaphylactoid reactions associated with parenteral cyclosporine use: possible role of Cremophor EL

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the histamine-releasing activity of cremophor E1 and some of its derivatives in two experimental models: the in vivo anaesthetized dog and in vitro rat peritoneal mast cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microemulsions with timolol as potential eye drops

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo studies on plasma-to-blood ratio of paclitaxel in human, rabbit and rat blood fractions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2011/854872

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34557766&oldid=2143603044"